Department of Cardio-Renal Physiopathology, INC Ignacio Chávez, Mexico City 14080, Mexico.
Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, IPN Mexico City 11340, Mexico.
Int J Mol Sci. 2019 Nov 16;20(22):5764. doi: 10.3390/ijms20225764.
Chronic vasopressin secretion induced by recurrent mild heat stress exposure is significantly enhanced by limited rehydration with a fructose-containing beverage both in rodents and in humans. Moreover, this effect has been associated with upregulation of the polyol-fructokinase pathway and increased renal oxidative stress. Previously, we have shown that pharmacological inhibition of both V1a and V2 vasopressin receptors with conivaptan improved such renal alterations. The aim of this study was to evaluate the independent contributions of V1a and V2 receptors to the renal damage caused by mild heat stress and limited rehydration with a fructose-containing beverage. Osmotic minipumps were used to deliver either relcovaptan (0.64 mg/day) or tolvaptan (0.25 mg/day) in male Wistar rats for two weeks. Corresponding dilution vehicles were used as controls. To induce dehydration, rats were exposed to mild heat stress (37 °C for 1 h, Monday to Friday). All groups received a 10% fructose solution as a rehydration fluid for 2 h after mild heat stress. For the remainder of the day and on weekends, rats received tap water. The independent blockade of either the V1a or the V2 receptor prevented renal damage, reduced oxidative stress, and decreased plasma cortisol and systemic inflammation. However, the beneficial effects were regulated by different mechanisms. Tolvaptan inhibited polyol-fructokinase pathway overactivation, while relcovaptan prevented upregulation of the renin-angiotensin system and SGK1 expression. These data suggest that both V1a and V2 receptors participate in renal damage caused by heat stress-induced dehydration when fructose-containing beverages are used as rehydration fluids.
反复轻度热应激暴露引起的慢性血管加压素分泌,通过有限的含果糖饮料再水化,在啮齿动物和人类中均显著增强。此外,这种效应与多元醇果糖激酶途径的上调和肾脏氧化应激增加有关。此前,我们已经表明,用伐尼普坦(conivaptan)抑制 V1a 和 V2 血管加压素受体的药理学作用,可以改善这种肾脏改变。本研究的目的是评估 V1a 和 V2 受体对轻度热应激和含果糖饮料有限再水化引起的肾脏损伤的独立贡献。渗透微泵用于在雄性 Wistar 大鼠中递送盐酸伐尼普坦(relcovaptan)(0.64mg/天)或托伐普坦(tolvaptan)(0.25mg/天),持续两周。相应的稀释剂作为对照。为了诱导脱水,将大鼠暴露于轻度热应激(37°C 1 小时,周一至周五)。所有组在轻度热应激后 2 小时内均接受 10%果糖溶液作为再水化液。在其余时间和周末,大鼠接受自来水。单独阻断 V1a 或 V2 受体可预防肾脏损伤,减轻氧化应激,并降低血浆皮质醇和全身炎症。然而,有益作用是通过不同的机制调节的。托伐普坦抑制多元醇果糖激酶途径的过度激活,而盐酸伐尼普坦可防止肾素-血管紧张素系统和 SGK1 表达的上调。这些数据表明,当含果糖饮料用作再水化液时,V1a 和 V2 受体均参与由热应激诱导的脱水引起的肾脏损伤。